Prognosis and chemosensitivity using a five monoclonal antibody IHC test in node negative, tamoxifen-treated, ER+ breast cancer - NSABP B14 and B20 trials. Poster at the ASCO 2007 Breast Cancer Symposium
Chemosensitivity and stratification by a five monoclonal antibody IHC test in the NSABP B20 trial. Poster at ASCO 2007
A Five Antibody Prognostic IHC Test Identifies Estrogen Receptor Positive Patients Classified as Luminal B at High Risk for Tumor Progression. Poster at the American Association for Cancer Research (AACR) Annual Meeting 2007
Validation of a prognostic algorithm based upon a five monoclonal antibody immunohistochemistry test in Tamoxifen- treated, node negative breast cancer: NSABP B14 and B20 studies. Poster at San Antonio Breast Cancer Symposium 2006
Novel prognostic immunohistochemical biomarker panel for estrogen receptor-positive breast cancer. Journal of Clinical Oncology, vol 24, No 19 (July 1) 2006: 3039-3047
Validation of a five reagent immunohistochemistry assay for prognostication of estrogen-receptor expressing breast cancer. Poster at American Society of Clinical Oncology 2006
A novel prognostic immunohistochemical biomarker panel for estrogen receptor expressing breast cancer. San Antonio Breast Cancer Symposium (SABCS) Poster 2005
Translating gene expression patterns into IHC diagnostics for breast cancer: novel IHC reagents predict recurrence in a retrospective cohort at the Comprehensive Cancer Institute of Huntsville. San Antonio Breast Cancer Symposium (SABCS) Poster 2004
^top
|
 |
|
| |
|
|
|
Translation of breast cancer gene expression profiles into an immunohistochemistry-based classifier. Poster at the American Association for Cancer Research (AACR) Annual Meeting 2007
Translation of gene expression patterns into immunohistochemistry biomarkers. American Association for Cancer Research (AACR) Poster 2006
Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer.Breast Cancer Research 2005, 7:143-148
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome. Am J Pathol. 161(6):1991-6 (2002)
Reclassifying cancer, guided by genomics.
Cover Story CAP Today (College of American Pathologists) Jan. 2001
^top
|
 |
|
| |
|
|
|
Discovery and validation of novel biomarkers for prediction of recurrence and treatment response. Poster at International Association for the Study of Lung Cancer World Conference on Lung Cancer 2006
From gene expression patterns to IHC diagnostics: Discovery and validation of novel biomarkers for prediction of recurrence in non-small cell carcinoma of the lung (NSCLC). Oral Presentation at American Society of Clinical Oncologists (ASCO) 2005
^top
Utility of immunohistochemistry tissue array in the prediction of epithelial ovarian carcinoma response to therapy. American Society of Clinical Oncologists (ASCO) Poster 2005
Gene expression patterns in ovarian carcinomas. Mol Biol Cell. (11):4376-86. (2003)
^top
A Differentiation based immunohistochemical classifier that is prognostic for head and neck tumor patients. Poster at 2007 United States and Canadian Academy of Pathology (USCAP) Annual Meeting
^top
Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. Modern Pathology (2007) 20, 76-83
^top
The Novel Marker, DOG1 , Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status. American Journal of Pathology, Vol. 165, No. 1, July 2004
^top
|
 |
|
| |
|
|
|
Gene expression patterns within cell lines are predictive of chemosensitivity. American Association for Cancer Research (AACR) Poster 2006
Microarrays and molecular markers for tumor classification.
Genome Biology 2002;3(5): 3-6.
A comparison of gene expression signatures from breast tumors and breast tissue derived cell lines.
Dis Markers. 2001;17(2): 99-109.
Towards a novel classification of human malignancies based on gene expression patterns.
J Pathol. 2001 Sep;195(1): 41-52.
Rerg is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer.
J Biol Chem 2001 Nov 9;276(45): 42259-67.
Systematic variation in gene expression patterns in human cancer cell lines.
Nat Genet. 2000 Mar;24(3): 227-35.
A gene expression database for the molecular pharmacology of cancer.
Nat Genet 2000 Mar;24(3):236-44
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers.
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16): 9212-7.
^top
|
 |
|
| |
|
|
|
A pilot project for generation of rabbit monoclonal antibodies and an immunohistochemistry database exploring the proteome. Poster at Human Protein Organization (HUPO) Congress 2006
Follicular Dendritic Cell Immunohistochemical Markers in Angioimmunoblastic T-Cell Lymphoma Appl Immunohistochem Mol Morphol 2005;13:297-303
^top
|
